Canadian Agency for Drugs and Technologies in Health. (2018). Pharmacoeconomic review report: Nusinersen (Spinraza) (Biogen Canada Inc.). Canadian Agency for Drugs and Technologies in Health.
Chicago Style (17th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Nusinersen (Spinraza) (Biogen Canada Inc.). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2018.
MLA (9th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Nusinersen (Spinraza) (Biogen Canada Inc.). Canadian Agency for Drugs and Technologies in Health, 2018.
Warning: These citations may not always be 100% accurate.